Study Design Time-span Sample Age (years) [adjustment for effect : ] Female [adjustment for effect : ] Migraine type (sample size if available) Medication Comorbid factors Night work/shift work Circadian variation of attack onset (peak) Studies showing a monophasic 24-hour cyclic manner of migraine attacks Solomon (1992) [9 ] prospective 20 weeks 15 patients (USA) no data no data MO, MA NSAID or placebo used (beta-blockers excluded) healthy (except migraine) no data Fox & Davis (1998) [6 ] retrospective last 3 years 1698 patients (USA) from 18 to 60+ 89% MO, MA use of oral contraceptives included no data included Fox (2005) [5 ] literature data analysis - 1698 patients (USA) from 18 (median: 34) ~4:1 MO, MA excluded w. oral contraceptives no data not included Gori, et al. (2005) [7 ] retrospective last 3 months 100 patients (Italy) patients (23-50), mean: 38.6; control (23-60), mean: 37.1 no data MO no data depression and anxiety symptoms; sleep quality no data Alstadhaug, et al. (2008) [3 ] prospective 12 months 84 patients (arctic) mean ~35 100% MO (34), MO+MA (50) use of oral contraceptives, beta-blockers included healthy (except migraine); insomnia included at Park, et al. (2018) [8 ] prospective 90 days 82 patients (Korea) mean 37.4 84.1% MO (81), MA (1) use of acute & preventive medication allowed non-migraine type headache not included Studies showing a biphasic 24-hour cyclic manner of migraine attacks Soriani, et al. (2006) [11 ] prospective 12 months 115 patients (pediatric) (Italy) 5-18 yrs (median: ~10) 47% [ ] MO excluded if taking prophylactic medication no data - main peak at 4:4 , secondary peak at 6:3 Alstadhaug, et al. (2007) [12 ] prospective 12 months 68 patients (arctic) mean 35.5 100% MO, MA (insomnia-related (29%) & not related attacks) excluded if taken beta-blockers possible chronic insomnia; sleep quality on the night prior to or the night of the attack not included insomnia related: peak early in the morning (~ ) & just after noon/not related: peak just after noon van Oosterhout, et al. (2018) [10 ] cross-sectional - 2389 patients, 189 controls (Dutch) mean 45.2 [ ] 83.4% [ ] MO, MA use of sleep medication (no data on migraine medication) depression and anxiety symptoms, lifetime depression; sleep quality included peaks: from midnight to (34.5%) & from to noon (31.7%) de Tommaso & Delussi (2018) [13 ] prospective 3 months 786 cases (Italy) means: MO – 37.4; MO+MA – 34.2; CM – 42.5 [ ] ~80% MO (538), MO+MA (52), CM (196) exclusion: use of central nervous system-active drugs or preventive treatment for primary headache healthy (except migraine); depression and anxiety symptoms; sleep features; quality of life no data two peaks: at & at (but most patients did not report a constant circadian rhythm of their attacks)